Clinical Trial: First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics

U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516639) titled 'First-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics' on April 01.

Brief Summary: The goal of this clinical trial is to learn about a study drug called ISH0613 and how it behaves in healthy adults.

This study will also evaluate the safety and tolerability of ISH0613 after a single intravenous (IV) dose.

The main questions this study aims to answer are:

I. What medical problems (side effects) may occur after receiving ISH0613? How does ISH0613 move through and get processed in the body? II. Does ISH0613 affect certain biological markers related to the immune system? III. Researchers will co...